PTPN11, protein tyrosine phosphatase non-receptor type 11, 5781
N. diseases: 702; N. variants: 98
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.695 | 0.440 | 12 | 112477720 | missense variant | A/C;G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 0 | |||||||||||
|
0.752 | 0.280 | 12 | 112473023 | missense variant | A/C;G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 0 | |||||||||||
|
0.827 | 0.240 | 12 | 112450362 | missense variant | A/C;G;T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 25 | 2001 | 2016 | ||||||||
|
0.827 | 0.200 | 12 | 112450407 | missense variant | A/C;G;T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 13 | 2003 | 2016 | ||||||||
|
0.827 | 0.240 | 12 | 112450352 | missense variant | A/C;G;T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 0 | |||||||||||
|
0.662 | 0.440 | 12 | 112450368 | missense variant | A/G | snv | 1.2E-05 | 7.0E-06 |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 0 | |||||||||
|
0.752 | 0.280 | 12 | 112450416 | missense variant | A/G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 0 | |||||||||||
|
0.752 | 0.400 | 12 | 112477719 | missense variant | A/G | snv | 1.2E-05 | 7.0E-06 |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 0 | |||||||||
|
0.752 | 0.280 | 12 | 112489086 | missense variant | A/G | snv | 4.0E-06 |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 0 | ||||||||||
|
0.807 | 0.240 | 12 | 112450354 | missense variant | C/A;G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 0 | |||||||||||
|
0.742 | 0.280 | 12 | 112450395 | missense variant | C/A;G;T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 3 | 2003 | 2016 | ||||||||
|
0.742 | 0.320 | 12 | 112450398 | missense variant | C/T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.730 | 1.000 | 3 | 2004 | 2014 | ||||||||
|
0.701 | 0.280 | 12 | 112488466 | missense variant | C/T | snv | 4.0E-06 | 7.0E-06 |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 0 | |||||||||
|
0.708 | 0.560 | 12 | 112489083 | missense variant | G/A;C | snv | 4.0E-06 |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 13 | 2003 | 2017 | |||||||
|
0.708 | 0.440 | 12 | 112450406 | missense variant | G/A;C | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.870 | 1.000 | 10 | 2003 | 2019 | ||||||||
|
0.882 | 0.240 | 12 | 112450385 | missense variant | G/A;C | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 2 | 2003 | 2016 | ||||||||
|
0.776 | 0.280 | 12 | 112450361 | missense variant | G/A;C;T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.810 | 1.000 | 22 | 2003 | 2017 | ||||||||
|
0.732 | 0.280 | 12 | 112450394 | missense variant | G/A;C;T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 7 | 2003 | 2016 | ||||||||
|
0.790 | 0.360 | 12 | 112489084 | missense variant | G/A;C;T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 2 | 2003 | 2016 | ||||||||
|
0.658 | 0.520 | 12 | 112453279 | missense variant | G/C;T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.710 | 1.000 | 15 | 2002 | 2013 | ||||||||
|
0.790 | 0.240 | 12 | 112450408 | missense variant | G/C;T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 0 | |||||||||||
|
0.807 | 0.320 | 12 | 112489080 | missense variant | T/A;G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 12 | 2002 | 2013 | ||||||||
|
0.708 | 0.400 | 12 | 112450364 | missense variant | T/A;G | snv | 4.0E-06 |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 8 | 2002 | 2012 | |||||||
|
0.752 | 0.320 | 12 | 112473040 | missense variant | T/C;G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 0 |